Morcos Awad1, Andrea Ruzza2, James Mirocha3, Saman Setareh-Shenas4, J Robert Pixton4, Camelia Soliman4, Lawrence S C Czer4. 1. Division of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, California. lawrence.czer@cshs.org. 2. Division of Cardiothoracic Surgery, Cedars-Sinai Heart Institute, Los Angeles, California. 3. Section of Biostatistics, Cedars-Sinai Medical Center, Los Angeles, California. 4. Division of Cardiology, Cedars-Sinai Heart Institute, Los Angeles, California.
Abstract
BACKGROUND: Hypertension (HTN) is one of the causes of cardiovascular disease (CVD) in Africa, and may be associated with lower socio-economic status (SES). The prevalence of HTN is not well established in the Gambia or in Sierra Leone. METHODS: A cross-sectional, population-based study of adults was conducted in the Gambia in 2000 and in Sierra Leone from 2001 to 2003 and in 2009. The study was conducted as part of the annual visit to countries in western Africa sponsored by a medical delegation from California. People from the Gambia and Sierra Leone were examined by the medical delegation and blood pressures were measured. RESULTS: A total of 2 615 adults were examined: 1 400 females and 1 215 males. The mean systolic blood pressure (SBP) of the females was 134.3 ± 29.7 mmHg, mean diastolic blood pressure (DBP) was 84.5 ± 17.5 mmHg, and 46.2% were hypertensive. The mean SBP of the males was 132.8 ± 28.5 mmHg, mean DBP was 82.8 ± 16.2 mmHg, and 43.2% were hypertensive. Overall prevalence of HTN in the subjects was 44.8%. Mean SBP, mean DBP and HTN prevalence increased with age decade, both in males and females. In addition, after age adjustment (known age), females had higher mean SBP (p = 0.042), mean DBP (p = 0.001) and rate of occurrence of HTN (p = 0.016) when compared with males. CONCLUSIONS: Prevalence rates of HTN in the Gambia and Sierra Leone were higher than 40% in males and females, and may be a major contributor to CVD in both countries. Due to the association of HTN with low SES, improvements in educational, public health, economic, non-governmental and governmental efforts in the Gambia and Sierra Leone may lead to a lower prevalence of HTN. The cause of the higher prevalence in women may be due to post-menopausal hormonal changes.
BACKGROUND:Hypertension (HTN) is one of the causes of cardiovascular disease (CVD) in Africa, and may be associated with lower socio-economic status (SES). The prevalence of HTN is not well established in the Gambia or in Sierra Leone. METHODS: A cross-sectional, population-based study of adults was conducted in the Gambia in 2000 and in Sierra Leone from 2001 to 2003 and in 2009. The study was conducted as part of the annual visit to countries in western Africa sponsored by a medical delegation from California. People from the Gambia and Sierra Leone were examined by the medical delegation and blood pressures were measured. RESULTS: A total of 2 615 adults were examined: 1 400 females and 1 215 males. The mean systolic blood pressure (SBP) of the females was 134.3 ± 29.7 mmHg, mean diastolic blood pressure (DBP) was 84.5 ± 17.5 mmHg, and 46.2% were hypertensive. The mean SBP of the males was 132.8 ± 28.5 mmHg, mean DBP was 82.8 ± 16.2 mmHg, and 43.2% were hypertensive. Overall prevalence of HTN in the subjects was 44.8%. Mean SBP, mean DBP and HTN prevalence increased with age decade, both in males and females. In addition, after age adjustment (known age), females had higher mean SBP (p = 0.042), mean DBP (p = 0.001) and rate of occurrence of HTN (p = 0.016) when compared with males. CONCLUSIONS: Prevalence rates of HTN in the Gambia and Sierra Leone were higher than 40% in males and females, and may be a major contributor to CVD in both countries. Due to the association of HTN with low SES, improvements in educational, public health, economic, non-governmental and governmental efforts in the Gambia and Sierra Leone may lead to a lower prevalence of HTN. The cause of the higher prevalence in women may be due to post-menopausal hormonal changes.
Hypertension (HTN) is a chronic, slowly progressive disease affecting about one
billion people globally and leading to about 7.1 million deaths annually. People of
African origin may be particularly susceptible to hypertension.1-3 Defined as a
sustained systolic blood pressure (SBP) above 140 mmHg, a diastolic blood pressure
(DBP) above 90 mmHg or both, the aetiology of HTN can be classified as primary or
secondary. While there is no known cause for primary (essential) HTN, which accounts
for 90–95% of cases, the remaining 5–10% of cases is defined as secondary HTN and is
caused by other disease conditions, which may affect the renal, circulatory,
endocrine or other organ systems.Many factors are associated with, and may contribute to the development and
persistence of primary HTN, including obesity, stress, smoking,4 low potassium intake, high sodium (salt) and alcohol
intake,5,6 familial and genetic influences,7,8 and low birth weight.9 On the other hand, hyperthyroidism,
hypothyroidism and other conditions causing hormonal changes may be associated with
primary pulmonary HTN.10,11 Regardless of the cause, the consequences of
HTN include renal failure, heart failure, myocardial infarction, pulmonary oedema
and stroke.12Given these undesirable outcomes, treatment and prevention have assumed increasing
emphasis in the management of HTN. Modification of risk factors can be achieved by
reducing body weight and decreasing sugar intake, along with lowering alcohol
consumption,13,14 as well as reducing salt intake and increasing potassium
intake.15,16 Secondary HTN is managed by treating the underlying cause. Drugs
available for the treatment of HTN, whether primary or secondary, include
calcium-channel blockers (CCB), angiotensin converting enzyme inhibitors (ACEI),
angiotensin receptor blockers (ARB), diuretics, α-blockers and β-blockers.Race and ethnicity may influence pathogenesis, prevalence and treatment of HTN,17 perhaps through genetic influences. As a
consequence, HTN remains one of the most common CVDs in Africa and one of the most
frequent causes of death in the sub-Saharan African region.18,19 In 2000, the rate
of HTN in sub-Saharan Africa was reported to be 26.9% in males and 28.3% in
females.20 Low socio-economic status
(SES) may additionally play an important role in the high prevalence of HTN in
western and sub-Saharan Africa.A cross-sectional survey in Tanzania revealed that treatment rates for HTN were very
low, especially among people with low SES.21
Low SES led to inadequate education levels as a factor correlating with a higher
blood pressure (BP) in adults and resulted in a low treatment rate for HTN due to
monetary issues.22Stress, in addition, was another factor related to HTN prevalence, especially in
Africa.23 It has been shown that
psychosocial stress affects the L-arginine/nitric oxide (NO) system, with a higher
susceptibility in black Africans, which in turn contributes to a higher risk of CVD
in those individuals.24Therefore, a multiplicity of factors may be associated with and contributing to a
high prevalence of HTN among Africans. The current study was undertaken to determine
and quantitate the prevalence of HTN in two countries in western sub-Saharan Africa,
namely, the Gambia and Sierra Leone.
Methods
This was a population-based, cross-sectional study performed in the Gambia and Sierra
Leone. The data were collected from the Gambia in 2000 and from Sierra Leone from
2001 to 2003 and in 2009. The Gambia is a small country, about 11 000 km2
in 2007, with a population of 1 705 000 by 2009.25,26 Sierra Leone is a larger
country, about 72 000 km2 in 2007, with a population of 5 696 000 by 2009.25,26This study took place as part of the annual visit to countries in western Africa
sponsored by a medical delegation from California. In the Gambia, the visit was to
specific areas within the capital city of Banjul, including Serrekunda, Latrikunda
and Fajikunda. In Sierra Leone, the medical delegation visited Freetown, Kenema,
Lunsar, Bonthe, Bo, Jui and Makeni.People waited in queues to be examined in a clinic by the team.27 Subjects underwent a history and general physical
examination, had their blood pressure checked, and were given medications depending
on the health issues they discussed with the healthcare providers. The current study
focused on the BP readings collected for adults aged ≥ 18 years.People coming for general examinations stayed in a waiting area in front of the
clinic to be triaged by a nurse before being checked by a physician. BPs were
measured using a sphygmomanometer. Patients whose BP fell in the hypertensive range
(SBP ≥ 140 mmHg, or DBP ≥ 90 mmHg) had their BP measured again once or twice by the
physician, depending on the initial BP. If more than one BP was recorded, an average
value was determined.In the Gambia and Sierra Leone, one of the additional procedures performed was
echocardiography using a hand-carried ultrasound (HCU) to assess left ventricular
hypertrophy (LVH) to prioritise HTN treatment.27 LVH was previously found in 65% of people with HTN.27
Statistical analysis
All the data collected during these visits, including BP measurements, medications
prescribed, and diagnostic tests, were recorded on a paper form and were later
entered in a computerised data spreadsheet and then de-identified. The study was
reviewed and certified by the institutional review board (IRB).Data were analysed statistically using the χ2-test, and the
p-values calculated were classified based on p
< 0.05 as considered of statistical significance. Other statistical tests
included the Fisher’s exact test, Cochran–Armitage trend test, Wilcoxon rank sum
test, Student’s t-test and ANCOVA multivariable-model test. The
data were analysed by country prior to and following the combination of both data
sets.Data from Sierra Leone were available for the years 2001–2003 and 2009. Differences
in SBP and DBP means were assessed across the years by analysis of covariance
(ANCOVA) models. The preliminary model was a two-way full factorial model with
factors gender and year and the gender-by-year interaction, and age was the
covariateIn the SBP model, the gender-by-year interaction term was significant
(p = 0.011), so separate one-way ANCOVA models were assessed in
females and males, with age as the covariate. In the DBP model, the gender-by-year
interaction term was not significant (p = 0.17); however, for
comparison, separate one-way ANCOVA models were assessed in females and males, with
age as the covariate. The least-squares means (LSmeans) for SBP and DBP were used to
present the findings.The data were divided into three categories: all adults with and without known
recorded age (n = 2 615), only adults with known age ≥ 18 years old
(n = 2 348) and only adults with known age ≥ 20 years old
(n = 2 247). There was one female who did not have a recorded
DBP.The first classification was used to have general demographics for the whole
population tested. The second and third classifications were used to observe trends
of SBP, DBP and HTN prevalence with age decade, starting with 20-year-old patients.
For all results including age decade analyses, the indications ≥ 70s and +70s stand
for the age decade 70 years and above, which were combined together with patients
over 80 years due to the small sample size in these older groups.
Results
In total, there were 2 615 adult participants: 46.5% males (n = 1
215) and 53.5% females (n = 1 400). Because one female lacked a
recorded DBP, the total number of individuals analysed based on SBP, DBP and HTN
prevalence were 2 615, 2 614 and 2 614 individuals, respectively.Of the overall population studied, 44.8% were hypertensive, while mean SBP was 133.6
± 29.2 mmHg and mean DBP was 83.7 ± 17.0 mmHg. For females, mean SBP was 134.3 ±
29.7 mmHg and mean DBP was 84.5 ± 17.5 mmHg, while 46.2% were hypertensive. For
males, mean SBP was 132.8 ± 28.5 mmHg and mean DBP was 82.8 ± 16.2 mmHg, while 43.2%
were hypertensive.The t-test showed no significant difference in mean SBP between
males and females (p = 0.18). However, for mean DBP, the
t-test indicated a significant difference between males and
females (p = 0.008), with females having a higher mean DBP.
Regarding HTN prevalence, the χ2-test showed that there was no
significant difference between males and females, and the Fisher’s exact test
confirmed this insignificance (p = 0.119 and p =
0.124, respectively).From the total number of subjects in the study (n = 2 615), a large
proportion (n = 2 348) represented individuals with known age ≥ 18
years old. The demographics of this subpopulation (Table 1) were compared across gender in terms of age, SBP and DBP means
using the t-test.
Table 1
Characteristics of patients with known age ≥ 18 years
Variable
Overall (n = 2 347)
F (n = 1 236**)
M (n = 1 111)
p-value unadjusted
p-value adjusted
Age (years)
39.6 ± 16.1
38.9 ± 15.9
40.5 ± 16.4
0.018*
SBP (mmHg)
133.2 ± 28.5
133.5 ± 28.6
132.8 ± 28.5
0.57*
0.042*
DBP (mmHg)
83.3 ± 16.7
84.0 ± 17.1
82.6 ± 16.1
0.049*
0.001*
HTN (%)
44.5
45.6
43.3
0.26†
0.016††
Values: mean ± SD or %.
**Females: n = 1 237 for SBP and age, and
n = 1 236 for DBP and HTN.
p-values for M vs F: *Student’s t-test,
†χ2-test, ††multivariable model
(odds ratio = 1.25). Adjustment: for age.
F = females, M = males, SD = standard deviation, SBP = systolic blood
pressure, DBP = diastolic blood pressure, HTN = hypertension.
Values: mean ± SD or %.**Females: n = 1 237 for SBP and age, and
n = 1 236 for DBP and HTN.p-values for M vs F: *Student’s t-test,
†χ2-test, ††multivariable model
(odds ratio = 1.25). Adjustment: for age.F = females, M = males, SD = standard deviation, SBP = systolic blood
pressure, DBP = diastolic blood pressure, HTN = hypertension.For mean age, males were older on average (p = 0.018). For mean SBP,
there was no evidence that SBP differed across gender; 133.5 mmHg for females and
132.8 mmHg for males (p = 0.57). However, after age adjustment,
females seemed to have a significantly higher SBP compared to males; 134.1 mmHg for
females and 132.1 mmHg for males (p = 0.042).In the case of mean DBP, there was a small difference across gender; 84.0 mmHg for
females and 82.6 mmHg for males (p = 0.049). After age adjustment,
there was a more significant evidence of the difference in DBP; 84.3 mmHg for
females and 82.2 mmHg for males (p = 0.001).For HTN, the χ2-test showed no difference across gender
(p = 0.26). However, after age adjustment using the
multivariable model, it seemed that females had higher odds and hence risk of HTN
than males (odds ratio = 1.25, p = 0.016).
SBP, DBP and HTN trends
From the total number of subjects with known age in the study (n = 2
348), a subdivision of this population (n = 2 247) represented
individuals with known age ≥ 20 years old. This subpopulation was used to examine
the SBP, DBP and HTN prevalence trends with age decade (Table 2).
Table 2
Characteristics of patients with known age ≥ 20 years
Age decade (years)
N
Gender
n
SBP ± SD (mmHg)
DBP ± SD (mmHg)
HTN % (n/N)
HTN Overall % (n/N)
20s
694
F
386
119.3 ± 19.1
76.0 ± 14.0
21.8 (84/386)
22.3
M
308
118.6 ± 16.9
74.9 ± 11.7
23.1 (71/308)†
(155/694)
30s
531
F
284**
125.4 ± 23.1
80.2 ± 15.4
33.8 (96/284)
33.9
M
247
124.7 ± 21.0
79.2 ± 13.5
34.0 (84/247)†
(180/531)
40s
373
F
190
143.0 ± 27.6
92.6 ± 16.8
66.3 (126/190)
58.4
M
183
136.3 ± 29.1
85.9 ± 16.8
50.3 (92/183)*
(218/373)
50s
312
F
159
151.3 ± 30.5
92.7 ± 16.3
71.7 (114/159)
69.9
M
153
150.1 ± 32.1
91.2 ± 15.3
68.0 (104/153)†
(218/312)
60s
201
F
96
160.8 ± 25.5
95.7 ± 13.1
86.5 (83/96)
80.1
M
105
155.9 ± 30.8
92.6 ± 16.8
74.3 (78/105)*
(161/201)
≥ 70s
135
F
65
158.0 ± 30.5
93.4 ± 17.9
81.5 (53/65)
75.6
M
70
153.3 ± 27.5
91.7 ± 14.8
70.0 (49/70)†
(102/135)
Values: mean ± SD or % (n/N).
**Females: n = 285 for SBP and age, and
n = 284 for DBP and HTN.
Fisher’s exact test: *significant differences, and
†insignificant differences.
F = females, M = males, SD = standard deviation, SBP = systolic blood
pressure, DBP = diastolic blood pressure, HTN = hypertension.
Values: mean ± SD or % (n/N).**Females: n = 285 for SBP and age, and
n = 284 for DBP and HTN.Fisher’s exact test: *significant differences, and
†insignificant differences.F = females, M = males, SD = standard deviation, SBP = systolic blood
pressure, DBP = diastolic blood pressure, HTN = hypertension.Mean SBP increased continually with age decade for males and females (Fig. 1). The rate of increase was similar
between the genders; the slopes of the regression lines for males and females were
8.036 and 8.806, respectively. As in the case of SBP, mean DBP increased continually
with age decade for males and females (Fig. 2).
The rate of increase was very similar between the genders; the slopes of the
regression lines for males and females were 3.696 and 3.824, respectively.
Fig. 1.
Mean SBP of patients with known age ≥ 20 years. Histogram of mean SBP ± SD.
Females = grey bars and dashed line, males = red bars and solid line.
Regression equations: y = 8.806x + 112.1
(R = 0.956) for females and y =
8.036x + 111.6 (R = 0.954) for males.
F = females, M = males, SD = standard deviation, SBP = systolic blood
pressure.
Fig. 2.
Mean DBP of patients with known age ≥ 20 years. Histogram of mean DBP ± SD.
Females = grey bars and dashed line, males = red bars and solid line.
Regression equations: y = 3.824x + 75.03
(R = 0.872) for females and y =
3.696x + 72.97 (R = 0.938) for males.
F = females, M = males, SD = standard deviation, DBP = diastolic blood
pressure.
Mean SBP of patients with known age ≥ 20 years. Histogram of mean SBP ± SD.
Females = grey bars and dashed line, males = red bars and solid line.
Regression equations: y = 8.806x + 112.1
(R = 0.956) for females and y =
8.036x + 111.6 (R = 0.954) for males.
F = females, M = males, SD = standard deviation, SBP = systolic blood
pressure.Mean DBP of patients with known age ≥ 20 years. Histogram of mean DBP ± SD.
Females = grey bars and dashed line, males = red bars and solid line.
Regression equations: y = 3.824x + 75.03
(R = 0.872) for females and y =
3.696x + 72.97 (R = 0.938) for males.
F = females, M = males, SD = standard deviation, DBP = diastolic blood
pressure.The Cochran–Armitage trend test showed significant differences in the HTN prevalence
between each age decade, overall and gender-wise (p < 0.0001).
This meant that within males, females, or overall scores, there was evidence that
HTN prevalence increased with age decade (Fig.
3). Meanwhile, female HTN prevalence appeared to be higher than that of
males in the age decades 40s, 50s, 60s, and +70s; however, the Fisher’s exact test
showed evidence for the difference only in the age decades 40s and 60s
(p = 0.002 and 0.035, respectively). The lack of significance
in the +70s group could have been due to the small sample size of this age
decade.
Fig. 3.
HTN prevalence in patients with known age ≥ 20 years. Histogram of HTN
prevalence rates (%). Females = grey bars and dashed line, males = red bars
and solid line. Regression equations: y =
13.2x + 14.06 (R = 0.935) for females
and y = 10.66x + 15.97 (R
= 0.944) for males. p-values: Fisher’s exact test. F =
females, M = males, HTN = hypertension.
HTN prevalence in patients with known age ≥ 20 years. Histogram of HTN
prevalence rates (%). Females = grey bars and dashed line, males = red bars
and solid line. Regression equations: y =
13.2x + 14.06 (R = 0.935) for females
and y = 10.66x + 15.97 (R
= 0.944) for males. p-values: Fisher’s exact test. F =
females, M = males, HTN = hypertension.Of note, the rate of increase in HTN prevalence was somewhat different between the
genders; the slopes of the regression lines for males and females were 10.66 and
13.2, respectively. In addition, there was a dramatic increase in HTN prevalence in
females between the age decades 30s and 40s, compared to that in males.
The Gambia and Sierra Leone patients
To check whether there were large differences in the demographics of subjects between
the Gambia and Sierra Leone, the collected records for the year 2000 in the Gambia
and the year 2001 in Sierra Leone were compared for the criteria SBP, DBP and HTN
prevalence. Only the year 2001 was chosen to represent the data collected from
Sierra Leone because the population sizes in the years 2000 and 2001 were comparable
(Table 3).
Table 3
Characteristics of patients with known age ≥ 18 years in the Gambia
(2000) and Sierra Leone (2001)
Variable
The Gambia (n = 560*)
Sierra Leone (n = 659)
p-value†
Age (years)
36.0 ± 15.3
39.5 ± 16.0
0.0001
SBP (mmHg)
126.7 ± 26.1
132.1 ± 24.6
0.0002
DBP (mmHg)
80.4 ± 15.8
81.5 ± 14.5
0.21
Values: mean ± SD.
*The Gambia: n = 561 for age and SBP and
n = 560 for DBP.
Values: mean ± SD.*The Gambia: n = 561 for age and SBP and
n = 560 for DBP.†Student’s t-test.SD = standard deviation, SBP = systolic blood pressure, DBP = diastolic
blood pressure.The χ2-test indicated more females and fewer males in the Gambia
(p < 0.0001). The t-test showed that DBP
means seemed to be similar between subjects from both countries (p
= 0.21), while age and SBP means seemed to be different (p = 0.0001
and p = 0.0002, respectively), with Sierra Leone having higher
means.Furthermore, SBP and DBP means continually increased with age decade for both the
Gambia and Sierra Leone subjects (Figs 4 and
5, respectively). In Sierra Leone, there
were higher SBP means in the age decades 20s and 30s (p = 0.013 and
p = 0.002, respectively) and lower SBP means in the age decade
≥ 70s (p = 0.026) in comparison with SBP means in the Gambia, as
shown in Fig. 4.
Fig. 4.
Mean SBP of patients with known age ≥ 20 years in the Gambia (2000) and
Sierra Leone (2001). Histogram of mean SBP ± SD. The Gambia = grey bars and
dashed line, Sierra Leone = red bars and solid line. Regression equations:
y = 10.04x + 103.8 (R
= 0.989) for the Gambia and y = 6.318x +
116.4 (R = 0.903) for Sierra Leone.
p-values: Student’s t-test. G = the
Gambia, S = Sierra Leone, SD = standard deviation, SBP = systolic blood
pressure.
Fig. 5.
Mean DBP of patients with known age ≥ 20 years in the Gambia (2000) and
Sierra Leone (2001). Histogram of mean DBP ± SD. The Gambia = grey bars and
dashed line, Sierra Leone = red bars and solid line. Regression equations:
y = 4.575x + 70.43 (R
= 0.990) for the Gambia and y = 3.078x +
74.07 (R = 0.906) for Sierra Leone.
p-values: Student’s t-test. *Wilcoxon rank-sum test
p-value. G = The Gambia, S = Sierra Leone, SD =
standard deviation, DBP = diastolic blood pressure.
Mean SBP of patients with known age ≥ 20 years in the Gambia (2000) and
Sierra Leone (2001). Histogram of mean SBP ± SD. The Gambia = grey bars and
dashed line, Sierra Leone = red bars and solid line. Regression equations:
y = 10.04x + 103.8 (R
= 0.989) for the Gambia and y = 6.318x +
116.4 (R = 0.903) for Sierra Leone.
p-values: Student’s t-test. G = the
Gambia, S = Sierra Leone, SD = standard deviation, SBP = systolic blood
pressure.Mean DBP of patients with known age ≥ 20 years in the Gambia (2000) and
Sierra Leone (2001). Histogram of mean DBP ± SD. The Gambia = grey bars and
dashed line, Sierra Leone = red bars and solid line. Regression equations:
y = 4.575x + 70.43 (R
= 0.990) for the Gambia and y = 3.078x +
74.07 (R = 0.906) for Sierra Leone.
p-values: Student’s t-test. *Wilcoxon rank-sum test
p-value. G = The Gambia, S = Sierra Leone, SD =
standard deviation, DBP = diastolic blood pressure.The increase in mean SBP seemed to be faster in the Gambia when compared with Sierra
Leone, based on the regression line slopes of 10.04 and 6.32, respectively (Fig. 4). Similarly, the increase in mean DBP
seemed to be faster in the Gambia when compared with Sierra Leone, based on the
regression line slopes of 4.58 and 3.08, respectively (Fig. 5). As shown in Fig. 5, DBP
mean in the Gambia was higher than in Sierra Leone in the age decade ≥ 70s
(p = 0.041). The Wilcoxon test was more trusted for the small
sample size, which was the case in the age decade ≥ 70s.HTN prevalence appeared to be continually increasing with age decade for both the
Gambia and Sierra Leone (Fig. 6). However, this
increase seemed to be occurring at a faster rate in the Gambia than in Sierra Leone,
as detected by the trend line slopes of 14.07 and 10.30, respectively. In addition,
HTN prevalence in Sierra Leone was higher in the age decades 20s and 50s
(p < 0.0001 and p = 0.015, respectively)
compared to HTN prevalence in the Gambia.
Fig. 6.
HTN prevalence in patients with known age ≥ 20 years in the Gambia (2000) and
Sierra Leone (2001). Histogram of HTN prevalence rates (%). The Gambia =
grey bars and dashed line, Sierra Leone = red bars and solid line.
Regression equations: y = 14.07x – 0.293
(R = 0.957) for the Gambia and y =
10.30x + 20.44 (R = 0.963) for Sierra
Leone. p-values: Fisher’s exact test. HTN = hypertension. G
= the Gambia, S = Sierra Leone.
HTN prevalence in patients with known age ≥ 20 years in the Gambia (2000) and
Sierra Leone (2001). Histogram of HTN prevalence rates (%). The Gambia =
grey bars and dashed line, Sierra Leone = red bars and solid line.
Regression equations: y = 14.07x – 0.293
(R = 0.957) for the Gambia and y =
10.30x + 20.44 (R = 0.963) for Sierra
Leone. p-values: Fisher’s exact test. HTN = hypertension. G
= the Gambia, S = Sierra Leone.Overall, among adults with known age ≥ 20 years old, the HTN prevalence rates in the
Gambia in 2000 and in Sierra Leone in 2001 were 32.4 and 46.6%, respectively, while
the Fisher’s exact test showed a significant difference between both values
(p < 0.0001). The Cochran–Armitage trend test showed a
significant difference between the HTN prevalence of each age decade by country
(p < 0.0001).
Sierra Leone patients
To check whether there was a trend in the data collected in Sierra Leone over the
years 2001–2003 and 2009, ANOVA was performed on SBP and DBP LSmeans, adjusted for
the relationship with age and separated by gender (Table 4). Adjusted for age, SBP LSmean in females was similar between
2009 and 2003 (p = 0.84), higher in 2003 than in 2001
(p = 0.003), and higher in 2001 than in 2002
(p = 0.014). DBP LSmean in females was higher in 2003 than in
2009 (p = 0.0002), similar between 2009 and 2001
(p = 0.13), similar between 2001 and 2002 (p =
0.35), and lower in 2002 than in 2009 and 2003 (p = 0.029 and
p < 0.0001, respectively).
Table 4
Characteristics of patients with known age ≥ 18 years in Sierra
Leone
Data collection year
Gender
N
SBP (mmHg)
p-values
DBP (mmHg)
p-values
2001*
F
297
135.1
0.014, 0.003
83.0
0.35, < 0.0001
M
362
131.7
0.73, < 0.0001
81.3
0.41, < 0.0001
2002**
F
304
130.1
< 0.0001, < 0.0001
81.8
< 0.0001, 0.029
M
359
132.3
< 0.0001, 0.002
82.2
< 0.0001, 0.068
2003†
F
209
141.8
0.84
92.6
0.0002
M
74
150.7
0.043
95.9
< 0.0001
2009††
F
108
142.4
0.010
85.6
0.13
M
74
142.4
0.0009
85.5
0.022
Values: least squares means (LSmeans).
p-values: *2001 vs 2002 and 2003, respectively, **2002
vs 2003 and 2009, respectively, †2003 vs 2009,
††2009 vs 2001.
F = females, M = males, SBP = systolic blood pressure, DBP = diastolic
blood pressure.
Values: least squares means (LSmeans).p-values: *2001 vs 2002 and 2003, respectively, **2002
vs 2003 and 2009, respectively, †2003 vs 2009,
††2009 vs 2001.F = females, M = males, SBP = systolic blood pressure, DBP = diastolic
blood pressure.After age adjustment, SBP LSmean in males was higher in 2003 than in 2009
(p = 0.043), higher in 2009 than in 2002 (p =
0.002), and similar between 2002 and 2001 (p = 0.73). DBP LSmean in
males was higher in 2003 than in 2009 (p < 0.0001), similar
between 2009 and 2002 (p = 0.068), similar between 2002 and 2001
(p = 0.41), lower in 2001 than in 2009 and 2003
(p = 0.022 and p < 0.0001, respectively).
To summarise, SBP and DBP LSmeans were generally higher in 2003 and 2009 compared to
those in 2001 and 2002.Mean SBP was shown to increase with age decade in both males and females (Fig. 1). There was a significant difference in
mean SBP between the genders after age adjustment, with females having a higher mean
SBP. Previous studies in Kenya, Tanzania, the Gambia and West Africa showed an
increase in SBP with increasing age in both genders.1,21,23,28 The study in
Tanzania showed that the increase in mean SBP with age was steeper in females.21Mean DBP increased with age decade and then plateaued as age decade reached +70s in
both males and females (Fig. 2), which was
similar to a previous study in the Gambia.23
Prior studies showed that mean DBP increased with age and then plateaued by ages
45–54 and 55–64 years in Tanzania and West Africa, respectively.21,28
Our study showed that females had a higher mean DBP than males after age
adjustment.HTN prevalence was shown to increase with age decade for both males and females (Fig. 3). Previous studies in Sierra Leone, Kenya
and West Africa showed that HTN prevalence rates increased with age in both
genders.1,28,29 Comparing males to females,
we found that females had higher odds and risk of HTN than males. Similarly, studies
in Tanzania and Uganda showed that HTN was significantly higher in females.21,30
This may have been due to post-menopausal hormonal changes.31 Females showed a relatively higher HTN prevalence, starting
with the age decade 40s and above (Fig. 3),
consistent with post-menopausal hormonal changes related to the observed increase in
androgen levels post menopause.32Knowing that obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is a risk factor for
developing HTN, post-menopausal women with OSAHS showed a higher prevalence of HTN
when compared to those without OSAHS and to all pre-menopausal women.33 It was also noted in the same study that
among females with OSAHS, post-menopausal women had higher SBP and DBP averages when
compared to pre-menopausal women. This may have been due to falling oestrogen levels
in post-menopausal women, because oestrogen decline causes a rise in BP via the
activation of the renin–angiotensin system, which in turn explains the observed
higher plasma renin levels in post-menopausal females compared to males and
pre-menopausal females.32Furthermore, endothelin levels are higher in post-menopausal females, which explains
in part the observed higher BPs, since endothelin causes sodium re-absorption, which
in turn causes higher BP.32 All of these
factors make increasing age a risk factor of acquiring HTN in females, considering
also the observation that about 60% of females aged > 65 years are
hypertensive.32
HTN in Sierra Leone and the Gambia
This study highlights the high prevalence of HTN in the Gambia and Sierra Leone. HTN
seems to be highly prevalent as a CVD in the sub-Saharan African region,19 and may be rising over time. In 2006, a
cross-sectional study in Uganda revealed that 252 individuals out of the 842
participants (29.9%) were hypertensive.30 In
2007–2008, a study in Kenya found that 50.1% of 4 396 subjects were
hypertensive.1 In 1991–1995, HTN
prevalence in rural and urban Cameroon was 17.3%; however, in 2003, the rate rose by
an additional 7.3%.34HTN in Sierra Leone was reviewed in several studies. Between 1983 and 1992, HTN
accounted for about 7.5% on average of all deaths in Freetown, the capital of Sierra
Leone.35 A retrospective study, published
in 1993, showed that among 87 subjects, 59 individuals were hypertensive.36HTN prevalence, according to the HTN definition of ≥ 160/95 mmHg, was measured in
four Sierra Leonean towns and villages. In 1998, in Njala Komboya and Kychum, HTN
prevalence was 24.8 and 17.6%, respectively.37 Similarly, in 1999, HTN prevalence was 23.4 and 14.7% in Freetown and
Port Loko, respectively.38 Recently, in Bo in
2009, 25.2% of 3 944 individuals aged ≥ 15 years old were hypertensive according to
the HTN definition of ≥ 140/90 mmHg; however, the study showed no difference in BPs
between males and females.29 HTN prevalence
by calendar year seems to agree with our results, showing that SBP and DBP LSmeans
tended to be higher in the later years (2003 and 2009) than in the earlier years
(2001 and 2002).Several studies reviewed HTN in the Gambia. In 1996–1997, the HTN prevalence,
according to the definition of ≥ 160/95 mmHg, was 7.1%, whereas by 1998, it rose to
10.2%, an increase of 3.1% in a year.34
According to the HTN definition in the current study (≥ 140/90 mmHg), van der Sande
showed in 1997 that 24.2% of 6 048 individuals in the Gambia were hypertensive.23 Although the prevalence of HTN seems to be
high in the Gambia, a study in 2001 pointed out that HTN prevalence in the Gambia
varies with the specific geographical area in the country.39These results show the high prevalence rate of HTN in the Gambia and Sierra Leone.
Comparatively, in our current study, the HTN prevalence rate in both countries
combined was 46.2% among females (n = 1 399), 43.2% among males
(n = 1 215), and 44.8% overall (n = 2
614).
Influence of low SES
One major dilemma in sub-Saharan Africa is the low SES of countries in the region,
including the Gambia and Sierra Leone. It was estimated that the total number of
hypertensive adults in developing countries in 2000 was 639 million, compared to 333
million in developed countries,20 which is a
result of the difference in SES.18The low SES establishes a variety of factors contributing to the prevalence of HTN,
including a low HTN treatment rate, low levels of education and awareness, high salt
and low potassium intakes, as well as an increased stress level. All these factors
contribute directly or indirectly to the HTN prevalence rate among countries in the
sub-Saharan African region.18,34 Evidently, low SES was linked to high BP
means, with a stronger effect on females than males.40
HTN treatment and SES
The treatment rate of a chronic disease depends on several factors, including the
cost of the treatment associated with the disease. As mentioned, the SES of Sierra
Leone and the Gambia is low and this may contribute to lack of availability of
antihypertensive treatment.18 A study in
Kenya showed that only 15% of hypertensive individuals were able to obtain treatment
for HTN.1 A low SES contributed to the
government not having adequate amounts of medications to distribute among
patients.In a 1999 survey in Cape Town, South Africa, 15.5% of patients reported that during
filling prescriptions, insufficient medication was supplied.41 A low SES also contributed to individual patients not having
enough income to pay for the medications. In the Gambia, in 2006, the rate of
unemployment was high.42 Therefore, the
inability to obtain medication was a factor contributing to the high HTN prevalence
rate.
Education levels and SES
The awareness of HTN was previously correlated with the prevalence rate of the
disease.22 This awareness is usually
provided by schools as well as public healthcare facilities. Establishment of
schools has been difficult in societies with low SES. Concerning school education,
in the Gambia, a research study showed that 10 and 56% of women aged 10–25
(n = 50) and 35–50 (n = 50) years,
respectively, were unable to read, whereas 34% of 50 males aged 35–50 years were
unable to read.42 A study in Tanzania also
pointed out that SBP was associated with education, which in turn was associated
with SES; the higher the SES, the lower the SBP.21Establishment and funding of public healthcare facilities, such as medical schools
and nursing schools, has also been difficult in low SES countries. In 2000–2010,
there were 0.4 physicians and 5.7 nurses and midwives per 10 000 individuals in the
Gambia, while in Sierra Leone, there were 0.2 physicians and 1.7 nurses and midwives
per 10 000 individuals. On the other hand, in the USA, there were 26.7 physicians
and 98.2 nurses and midwives per 10 000 individuals.26These low healthcare provider-to-population ratios (61/100 000 in the Gambia and
19/100 000 in Sierra Leone) reflect the inadequate establishment and funding of
public healthcare facilities in these countries. It is estimated that by 2015,
according to the needs-based model, there will be a total of 45 countries in the
world with physician shortage, 32 countries (~ 70%) of which are in Africa.43
Potassium and sodium levels and SES
HTN is related to sodium and potassium levels based on renin secretion, cellular
sodium–potassium pumps and therefore the individual’s nephron mass. The effect of
sodium and potassium levels on HTN in the Gambia and Sierra Leone depends on two
factors: the intrinsic propensities of the individual being of African descent and
the individual’s levels of salt intake, as well as vegetable and fruit (potassium)
intake. Research in the USA and Europe illustrated that people of African descent
had higher HTN prevalence and were at a higher risk of acquiring organ damage due to
HTN,23 in part because of lower nephron
mass, macula densa mass, sodium detection levels and sodium–potassium pump
activity.17,44,45It was found that higher SBP and DBP means were apparent in individuals with higher
sodium intake levels when compared with either intermediate or low sodium
intake.46 It has been shown that there is
a linearly increasing correlation between sodium intake and HTN prevalence and mean
SBP.47,48 Globally, it was estimated that sodium intake in children older than
five years of age was in excess by about 100 mmol/day.49 This was a significantly high sodium intake level,
considering that a high level of salt intake in infancy and childhood correlated to
a high BP later in life.50,51 In central and South Africa, it was found
that sodium levels in cells and in circulating blood were high in hypertensive
individuals.18In the Gambia, intake of salt-preserved foods was high due to inadequate
refrigeration. As a consequence, there was a high salt and sodium intake.23 A low SES reduces the likelihood for a
household to own a refrigerator and to receive electricity. In the Gambia, 14% of 50
females aged 14–25 years and 34% of 50 males aged 35–50 years did not receive
electricity at home.42 This electricity grid
showed inadequate electricity reception in Gambian households, leading to an
inability to refrigerate foods.Furthermore, dietary potassium intake was related to BP.52 Studies compared sodium to potassium intake and showed that
in lower SES communities, the ratio between sodium and potassium intakes was high;
however, the situation was nearly reversed in higher SES groups because potassium
intake was higher than that in lower SES groups.40 In Ghana, it was shown that an insufficient fruit and vegetable (a
source of potassium) intake in 39.6% of males and 38.2% of females was considered a
factor contributing to HTN prevalence.53
Therefore, this low potassium intake assists in maintaining a high HTN prevalence
rate.
Psychosocial status and SES
One of the factors contributing directly to an increased HTN prevalence is the
psychological status of the individual, affected by stressors correlating with low
SES. Studies have shown that stress, economic transition, and high BP may be
correlated.25,54As noted by a recent study, there is a significant association between psychosocialstress and endothelial dysfunction, which contributes to the development of
CVD.24 The study found that cold stress
caused a more prominent increase in DBP in white South Africans compared to black
South Africans. In addition, black Africans who reported higher levels of
psychosocial distress had lower L-arginine/ADMA (asymmetric dimethylarginine) ratio.
ADMA is known to be an inhibitor of the endothelial NO synthase, which produces NO
from L-arginine. The study concluded that psychological distress significantly
affects the L-arginine/NO system, with some ethnic differences.24In a low-SES community, employment levels are very low, therefore leading to an
increase in stress levels for individuals in a household due to the lack of an
income source to support a living. Another possible source of stress in the Gambia
and Sierra Leone was the instability in both societies. The instability in Sierra
Leone was due to the persisting civil war from 1991 to 2002, while in the Gambia, it
was due to their increasing potential population due to the outmigration of Sierra
Leoneans to surrounding countries, one of which was the Gambia. This instability
could have served as a psychological stressor that led to the increase in HTN
prevalence in both populations.
Additional HTN risk factors
Additional possible risk factors for HTN include smoking, alcohol consumption,
schistosomiasis specifically in the Gambia, and certain genotypic correlations.
Smoking is associated with CVD and increases HTN risk by two- to three-fold.55 In the Gambia, by 2006, 29.2% of males and
2.6% of females were tobacco smokers, compared to the USA, where 25.4% of males and
19.3% of females were tobacco smokers.26Alcohol intake also contributes to a higher BP and the prevalence of HTN.56 A study in Uganda considered past and
present alcohol intake as a risk factor associated with HTN prevalence.30 As for the Gambia and Sierra Leone, by 2005,
the total alcohol consumption among adults aged ≥ 15 years in the Gambia was 2.4%,
while in Sierra Leone, it was 6.5%, compared to 8.5% in the USA.26In the Gambia, schistosomiasis was another risk factor. Studies showed that
prevalence of diastolic hypertension in adults was two- to four-times higher in
Schistosoma haematobium endemic areas,23 including parts of the Gambia and Sierra Leone.Regarding genotypic influences, recent studies relate certain loci and some single
nucleotide polymorphisms in the human genome to BP and HTN. An admixture mapping
study identified a probable relatioship between chromosomes 6q24 and 21q21 and HTN
risk in African Americans.57 These two
regions included two loci on chromosome 21q, and five other markers on chromosome 6q
that suggested a genetic linkage to elevated BP.One genome-wide association study (GWAS) related three genes, previously associated
with BP in Americans of European descent, with BP in African Americans.58 The three genes were SH2B3,
TBX3-TBX5, and CSK-ULK3, all of which are genetic variants influencing
BP in African Americans, and generally in people of Africa descent.
Influences of lifestyle and economic development
Lifestyle changes, including smoking cessation, lower alcohol intake, sanitation,
clean water supply, refrigeration, and electricity access may influence HTN
prevalence (Fig. 7). The ability to make
lifestyle changes may be related to SES, educational level and economic
development.
Fig. 7.
Summary of possible lifestyle changes to lower HTN prevalence in the Gambia
and Sierra Leone. HTN = hypertension.
Summary of possible lifestyle changes to lower HTN prevalence in the Gambia
and Sierra Leone. HTN = hypertension.The economic development of both countries could raise both countries’ SES, thus
diminishing several factors contributing to HTN prevalence. Sources of economic
development in the Gambia and Sierra Leone could include the many natural resources
present in these countries, which could be used for economic self-sufficiency. With
economic development, both governments could offer funds for healthcare systems to
lower HTN prevalence.Concerning HTN awareness, healthcare providers in healthcare centres and religious
leaders in religious institutions could routinely make people aware of the disease,
its progression and burden, and its preventive means.53 The government could also establish national policies and programmes
so that all individuals, whether educated or not, would have an idea about the
existence of the disease HTN. In the Gambia, an improvement in education and disease
awareness is already underway.42Increased potassium (vegetable/fruit) intake and lowered sodium intake are needed for
protection against HTN.18,20,46
The high sodium (salt) intake is mainly due to the unavailability of food
preservation via refrigeration. Affordable electricity systems could be established
using the Berra Kunda waterfalls in the Gambia on the border with Senegal, and the
Bumbuna waterfalls in Sierra Leone for hydroelectric power.Chronic financial stress related to low SES and poor economic conditions is
potentially modifiable. A study in Ghana and Cameroon suggested that religious
institutions and leaders should encourage the people to overcome their financial
problems and to start a recovery process from their stress.53Considering schistosomiasis, the Gambia and part of Sierra Leone fall within the
endemic region of the disease.23,59 The main prevention against such parasitic
diseases is the improvement of drinking water sources and sanitation facilities.
Improper sanitation and water supply are related to ascariasis, diarrhoea, trachoma,
schistosomiasis and other diseases.60 An
analysis showed that cleaner water supplies led to a median reduction in
schistosomiasis morbidity rate of 69% for all studies and 77% for four selected
rigorous studies.60
Study limitations
Study limitations include the gap in data collection in Sierra Leone since the data
were collected from 2001 to 2003 and in 2009. The data from the Gambia were only
collected in 2000, which may result in a smaller sample size from the Gambia
contributing to the findings of the study. In addition, combining the data collected
from both countries could potentially be a weakness in the study, taking into
account the fact that there were some minor differences between the data collected
from the Gambia in 2000 and from Sierra Leone in 2001, as discussed above. Finally,
some ages were missing from the records, resulting in the exclusion of these
individuals from the statistical analyses involving age.
Conclusion
HTN was highly prevalent in the Gambia and Sierra Leone. This may have been due to
low HTN treatment rates, low education and awareness levels, low potassium and high
sodium intakes, and high stress levels, all of which are part of the persistently
low SES in both countries. Additional risk factors include smoking, alcohol
consumption, identified genetic loci and endemic diseases. Lifestyle changes need to
be instituted to lower this high prevalence of HTN. Changes include raising the
awareness of the disease, initiating a stress-recovery process, finding alternative
ways to preserve foods and improving sanitation and water supply sources.
Authors: Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He Journal: Lancet Date: 2005 Jan 15-21 Impact factor: 79.321
Authors: M A van der Sande; R Bailey; H Faal; W A Banya; P Dolin; O A Nyan; S M Ceesay; G E Walraven; G J Johnson; K P McAdam Journal: Trop Med Int Health Date: 1997-11 Impact factor: 2.622
Authors: Hua Jun Xu; Xiao Fei Lan; Qing Yun Li; Li Na Zhou; Xiu Juan Zhang; Qian Guo; Jin Hua Ni; Bei Cao Journal: Sleep Breath Date: 2014-05-08 Impact factor: 2.816
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Sergio L Kobal; Lawrence S C Czer; Peter C Czer; Zhanna Feldsher; Robert Hamilton; Robert J Siegel Journal: Chest Date: 2004-01 Impact factor: 9.410
Authors: Alon Unger; Ridalva D M Felzemburgh; Robert E Snyder; Guilherme S Ribeiro; Sharif Mohr; Vinícius B A Costa; Astrid X T O Melendez; Renato B Reis; Francisco S Santana; Lee W Riley; Mitermayer G Reis; Albert I Ko Journal: J Urban Health Date: 2015-06 Impact factor: 3.671
Authors: Maria Lisa Odland; Tahir Bockarie; Haja Wurie; Rashid Ansumana; Joseph Lamin; Rachel Nugent; Ioannis Bakolis; Miles Witham; Justine Davies Journal: BMJ Open Date: 2020-09-09 Impact factor: 2.692
Authors: Chiyembekezo Kachimanga; Anu Jegede Williams; Musa Bangura; Marta Lado; Sahr Kanawa; Daniel Lavallie; Michael Mhango; Haja Isatta Wurie; Marta Patiño Rodriguez Journal: Int J Nephrol Renovasc Dis Date: 2021-12-21
Authors: Maria Lisa Odland; Khadija Gassama; Tahir Bockarie; Haja Wurie; Rashid Ansumana; Miles D Witham; Oyinlola Oyebode; Lisa R Hirschhorn; Justine I Davies Journal: PLoS One Date: 2022-09-09 Impact factor: 3.752
Authors: Tessa J M Geraedts; Daniel Boateng; Karel C Lindenbergh; Diede van Delft; Hanna M Mathéron; Gulia L E Mönnink; Janine P J Martens; Daniel van Leerdam; Jonathan Vas Nunes; Sonnia-Magba Bu-Buakei Jabbi; Mohamed S Kpaka; Josien Westendorp; Alex J van Duinen; Osman Sankoh; Martin P Grobusch; Håkon A Bolkan; Kerstin Klipstein-Grobusch Journal: Trop Med Int Health Date: 2021-08-18 Impact factor: 3.918